Cargando…
Open-Label Placebo Treatment for Cancer-Related Fatigue: A Randomized-Controlled Clinical Trial
The purpose of this 21-day assessor blinded, randomized-controlled trial was to compare an open-label placebo (OLP) to treatment as usual (TAU) for cancer survivors with fatigue. This was followed by an exploratory 21-day study in which TAU participants received OLPs while OLP participants in the ma...
Autores principales: | Hoenemeyer, Teri W., Kaptchuk, Ted J., Mehta, Tapan S., Fontaine, Kevin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807541/ https://www.ncbi.nlm.nih.gov/pubmed/29426869 http://dx.doi.org/10.1038/s41598-018-20993-y |
Ejemplares similares
-
An Exploratory Analysis of the Association Between Catechol-O-Methyltransferase and Response to a Randomized Open-Label Placebo Treatment for Cancer-Related Fatigue
por: Hoenemeyer, Teri W., et al.
Publicado: (2021) -
Open-label placebos for menopausal hot flushes: a randomized controlled trial
por: Pan, Yiqi, et al.
Publicado: (2020) -
Open-label placebo treatment in chronic low back pain: a randomized controlled trial
por: Carvalho, Cláudia, et al.
Publicado: (2016) -
“Let’s see what happens:”—Women’s experiences of open-label placebo treatment for menopausal hot flushes in a randomized controlled trial
por: Pan, Yiqi, et al.
Publicado: (2022) -
Open-Label Placebo for the Treatment of Cancer-Related Fatigue in Patients with Advanced Cancer: A Randomized Controlled Trial
por: Yennurajalingam, Sriram, et al.
Publicado: (2022)